UCB-35440 is a 5-lipoxygenase inhibitor and a histamine H1 receptor antagonist potentially for the treatment of dermatitis. References: Hecq J, Deleers M, Fanara D, Vranckx H, Boulanger P, Le Lamer S, Amighi K. Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base. Eur J Pharm Biopharm. 2006 Nov;64(3):360-8. PubMed PMID: 16846725.

纯度：≥98%

CAS：299460-62-1